Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Debt to Equity (2016 - 2025)

Avanos Medical's Debt to Equity history spans 10 years, with the latest figure at $0.01 for Q3 2024.

  • For Q3 2024, Debt to Equity rose 50.68% year-over-year to $0.01; the TTM value through Sep 2024 reached $0.01, up 50.68%, while the annual FY2023 figure was $0.01, 96.14% down from the prior year.
  • Debt to Equity for Q3 2024 was $0.01 at Avanos Medical, up from -$0.03 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.18 in Q4 2022 and bottomed at -$0.32 in Q1 2024.
  • The 4-year median for Debt to Equity is $0.0 (2022), against an average of -$0.03.
  • The largest annual shift saw Debt to Equity surged 75.99% in 2022 before it plummeted 434.58% in 2023.
  • A 4-year view of Debt to Equity shows it stood at $0.1 in 2021, then soared by 75.99% to $0.18 in 2022, then crashed by 96.14% to $0.01 in 2023, then grew by 9.89% to $0.01 in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Debt to Equity are $0.01 (Q3 2024), -$0.03 (Q2 2024), and -$0.32 (Q1 2024).